CANDESARTAN ( DrugBank: Candesartan )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
58	肥大型心筋症	2
67	多発性嚢胞腎	2

58. 肥大型心筋症

臨床試験数 : 126 / 薬物数 : 135 - (DrugBank : 42) / 標的遺伝子数 : 46 - 標的パスウェイ数 : 162

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR-IIR-17013661	2018-10-10	2017-12-03	Effect of beta-blockers combined with angiotensin II receptor blockers in regression of cardiac hype ...	Effect of beta-blockers combined with angiotensin II receptor blockers in regression of cardiac hype ...	Hypertrophic cardiomyopathy	Experimental group:Metoprolol Succinate Sustained-release Tablets combined with candesartantreatment ...	The First Affiliated Hospital, Sun Yat-sen University	NULL	Recruiting	18	65	Both	Experimental group:130;Control group:130;	4 (Phase 4 study)	China
2	NCT00430833 (ClinicalTrials.gov)	March 2007	31/1/2007	CHANCE - Candesartan in Hypertrophic Cardiomyopathy	CandesartanUse in Hypertrophic and Non-Obstructive Cardiomyopathy Estate (The CHANCE): a Double-Blin ...	Hypertrophic Cardiomyopathy	Drug: candesartan	Charles University, Czech Republic	AstraZeneca	Active, not recruiting	18 Years	N/A	Both		Phase 2	Czech Republic

臨床試験数 : 221 / 薬物数 : 212 - (DrugBank : 55) / 標的遺伝子数 : 40 - 標的パスウェイ数 : 151

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00541853 (ClinicalTrials.gov)	December 2007	9/10/2007	CCB Safety Study in Treatment of Hypertension of ADPKD	Comparison Between ARB and ARB Plus CCB on Incidence of Renal and Cardiovascular Events in Hypertens ...	Kidney, Polycystic, Autosomal Dominant	Drug: Candesartan;Drug: Candesartan and Cilnidipine;Drug: Candesartan plus non-CCB agents	Kyorin University	Ministry of Health, Labour and Welfare, Japan	Not yet recruiting	20 Years	60 Years	Both	150	Phase 4	Japan
2	EUCTR2005-003182-16-GB (EUCTR)	26/08/2005	29/07/2005	Blood Pressure Optimisation In Patients With Polycystic Kidney Disease And Hypertension By Rotation ...	Blood Pressure Optimisation In Patients With Polycystic Kidney Disease And Hypertension By Rotation ...	Polycystic kidney disease	Trade Name: CARDURA Product Name: DOXAZOSIN Trade Name: MONOCOR Product Name: BISOPROLOL Trade Name: ZES ...	Addenbrooke's Hospital Trust	NULL	Not Recruiting			Female: yes Male: yes	42	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United Kingdom